methylophiopogonanone A: isolated from Ophiopogon japonicus; structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
| Flora | Rank | Flora Definition | Family | Family Definition |
|---|---|---|---|---|
| Ophiopogon | genus | A plant genus of the family Asparagaceae. Members contain steroidal glycosides and provide an ingredient of shengmaisan (DRUGS, CHINESE HERBAL).[MeSH] | Asparagaceae | A family of flowering subshrubs and shrubs in the class Magnoliopsida.[MeSH] |
| ID Source | ID |
|---|---|
| PubMed CID | 53466984 |
| CHEBI ID | 189526 |
| MeSH ID | M0538641 |
| Synonym |
|---|
| 74805-92-8 |
| methylophiopogonanone a |
| 4h-1-benzopyran-4-one,3-(1,3-benzodioxol-5-ylmethyl)-2,3-dihydro-5,7-dihydroxy-6,8-dimethyl-, (3r)- |
| AC-34355 |
| DTXSID60703469 |
| (3r)-3-[(2h-1,3-benzodioxol-5-yl)methyl]-5,7-dihydroxy-6,8-dimethyl-2,3-dihydro-4h-1-benzopyran-4-one |
| (3r)-3-(1,3-benzodioxol-5-ylmethyl)-5,7-dihydroxy-6,8-dimethyl-2,3-dihydrochromen-4-one |
| 8-methylophiopogonanone a |
| methylophiopogonanone a, analytical standard |
| A865797 |
| AKOS032949001 |
| HY-N2437 |
| CHEBI:189526 |
| CS-0022655 |
| MS-25235 |
| Class | Description |
|---|---|
| homoflavonoid | Any organic heteropolycyclic compound characterized by addition of an extra carbon atom to the C6-C3-C6 backbone of the flavonoid skeleton. They are commonly found in the genus Ophioglossum. |
| [compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] | |
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (8.33) | 29.6817 |
| 2010's | 4 (33.33) | 24.3611 |
| 2020's | 7 (58.33) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 13 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||